1. Attias J, Gordon C, Ribak J, Binah O, Rolnick A (1987) Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea. Aviat Space Environ Med 58:60–62
2. Brand JJ (1970) A survey of recent motion sickness research. J R Nav Med Serv 56:204–207
3. Brand JJ, Perry WLM (1966) Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods. Pharmacol Rev 18(1):895–924
4. Brand JJ, Colquhoun WF, Gould AF, Perry WLM (1965) A study of the relative potencies of l-hyoscine and cyclizine in preventing motion sickness, in preventing side effects, and in affecting mental performance. R.N.P. 66/1068, S.S. 155. Medical Research Council, Royal Naval Personnel Research Committee
5. Brazell C, Preston GC, Ward C, Lines CR, Traub M (1989) The scopolamine model of dementia: chronic transdermal administration. J Psychopharmacol 3:76–82